Average Daily Volume
25.6K
Fund Overview
The Global X Telemedicine & Digital Health ETF (HEAL) seeks to invest in companies positioned to benefit from the advancement of telemedicine and digital healthcare. This includes firms involved in telehealth platforms, digital health records, wearable health monitoring devices, and other healthcare technology innovations. HEAL provides exposure to a rapidly growing sector that is transforming traditional healthcare delivery through technology. The fund is designed for investors seeking long-term growth potential from the digitization of healthcare services and infrastructure.
- Asset Class
-
Equity
- Industry
-
Healthcare Services
- Annual Dividend Rate
-
- Smart Beta
-
No
- Leveraged / Inverse
-
N/A / No
- Dividend Quality - Yield
-
- 0.32 %
- Currency Hedged
-
No
- Portfolio Turnover
-
38 %
- Dividend Date
-
Our Sector Rotation Algorithm Makes the Difference
SectorSurfer pairs the power of a true sector rotation algorithm to own momentum leaders in Bull Markets with a defensive algorithm that invokes a Bear Market strategy to protect and grow your assets during downturns.
Boost returns by holding only momentum leaders
Choose from hundreds of ready-to-use strategies
Create custom strategies that fit your needs
Automatic trade signals with email alerts
Why Invest in the HEAL ETF?
Potential Benefits
- Provides targeted exposure to the fast-growing telemedicine and digital health sector.
- Offers diversification across companies innovating in healthcare technology.
- Potential for long-term growth as digital healthcare adoption increases globally.
- Lower expense ratio compared to some actively managed healthcare funds.
- Access to a niche market that may be underrepresented in broader healthcare ETFs.
Potential Risks
- Concentration risk in the healthcare technology sector.
- Regulatory changes could impact telemedicine adoption and reimbursement policies.
- Higher volatility compared to broad healthcare or market ETFs.
- Relatively new fund with limited performance history.
- Potential overvaluation of some digital health companies.
Histogram
MACD
Signal
Base Line
RSI data unavailable or insufficient history.
RSI (14)
Overbought (70)
Oversold (30)
Monthly Returns (%)
Year |
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec |
2025 |
+10.7%
|
-4.1%
|
-10.5%
|
+3.1%
|
+7.3%
|
+3.5%
|
+0.5%
|
-
|
-
|
-
|
-
|
-
|
2024 |
-7.7%
|
+0.9%
|
-0.5%
|
-6.3%
|
+2.1%
|
-2.7%
|
+2.7%
|
+4.2%
|
+3.8%
|
-2.8%
|
+7.9%
|
-4.4%
|
2023 |
+5.4%
|
-4.9%
|
-2.0%
|
+1.7%
|
-4.7%
|
+3.7%
|
+4.2%
|
-13.5%
|
-12.3%
|
-11.3%
|
+11.5%
|
+13.9%
|
2022 |
-16.0%
|
+2.7%
|
+2.0%
|
-13.9%
|
-4.4%
|
-2.2%
|
+9.0%
|
-5.3%
|
-6.7%
|
+2.8%
|
0.0%
|
+0.3%
|
2021 |
+8.9%
|
-4.2%
|
-7.1%
|
+6.5%
|
-7.7%
|
+5.7%
|
-6.2%
|
+0.6%
|
-3.4%
|
+2.7%
|
-9.4%
|
+0.7%
|
2020 |
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
+3.7%
|
+3.4%
|
+1.3%
|
+8.2%
|
+5.7%
|
2019 |
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
2018 |
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
2017 |
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
2016 |
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
0.0%
|
< -5%
-5% to -2%
-2% to 0%
0%
0% to +2%
+2% to +5%
> +5%
Top Holdings (by weight)
Symbol |
Company Name |
Weight |
HIMS
|
HIMS & HERS HEALTH INC ORDINARY SHARES CLASS A |
5.8 % |
MASI
|
MASIMO CORP |
4.7 % |
PODD
|
INSULET CORP |
4.5 % |
ISRG
|
INTUITIVE SURGICAL INC |
4.5 % |
DXCM
|
DEXCOM INC |
4.4 % |
DOCS
|
DOXIMITY INC CLASS A |
4.4 % |
VEEV
|
VEEVA SYSTEMS INC CLASS A |
4.2 % |
TMDX
|
TRANSMEDICS GROUP INC |
4.0 % |
RMD
|
RESMED INC |
3.9 % |
IRTC
|
IRHYTHM TECHNOLOGIES INC |
3.7 % |
Top 10 holdings shown, out of 39 total holdings.
Related ETFs: HEAL vs Peers
Comparison highlights key differences on cost, coverage, and focus within sector ETFs.
Investment Strategy
HEAL tracks the Solactive Telemedicine & Digital Health Index, which uses a modified market-cap weighting approach. The index includes companies that generate significant revenue from telemedicine, digital health platforms, or healthcare technology solutions. The fund primarily holds common stocks of these companies and is rebalanced quarterly to maintain its target exposure. HEAL's passive approach aims to provide cost-efficient exposure to the digital health sector without active stock selection.
Frequently Asked Questions
What types of companies does HEAL invest in?
HEAL invests in companies involved in telemedicine platforms, digital health records, remote patient monitoring, and other healthcare technology solutions.
How does HEAL differ from traditional healthcare ETFs?
HEAL focuses specifically on digital health innovators rather than the broader healthcare sector, which includes pharmaceuticals, hospitals, and insurance companies.
Is HEAL suitable for conservative investors?
HEAL may be too specialized and volatile for conservative investors, as it concentrates on a single, rapidly evolving segment of healthcare.
Does HEAL pay dividends?
HEAL may pay modest dividends, but its focus is primarily on growth companies in the digital health space rather than income generation.
What percentage of assets are in the top holdings?
As of the latest data, HEAL's top 10 holdings typically represent about 40-50% of total assets, reflecting moderate concentration.
Industry Overview
The telemedicine and digital health industry, represented by HEAL ETF, is experiencing rapid growth driven by technological advancements, changing patient preferences, and healthcare system efficiencies. The COVID-19 pandemic accelerated adoption of remote healthcare solutions, creating lasting structural changes in how care is delivered. This sector includes telehealth platforms, AI diagnostics, digital therapeutics, and health monitoring technologies. HEAL offers investors exposure to companies at the forefront of this transformation, which is expected to grow significantly as healthcare systems worldwide continue digitizing services to improve access and reduce costs.
Alternative Comparison
Compared to broader healthcare ETFs like XLV or VHT, HEAL offers more concentrated exposure specifically to digital health innovators. Among thematic healthcare funds, ARKG focuses more on genomics while IHI targets medical devices. HEAL's expense ratio is competitive with similar thematic healthcare ETFs, though slightly higher than broad sector funds. Unlike some actively managed healthcare funds, HEAL provides transparent, rules-based exposure to the digital health theme.
Issuer Overview
Global X ETFs, the issuer of HEAL, is known for its thematic and sector-specific ETFs. The firm specializes in creating targeted investment products that capture emerging trends and disruptive technologies. Global X manages a suite of healthcare-related ETFs and has demonstrated expertise in developing niche investment strategies within evolving market segments.
Conclusion
HEAL represents a focused investment in the transformative telemedicine and digital health sector. While offering growth potential from healthcare innovation, investors should be mindful of the fund's sector concentration and higher volatility compared to diversified healthcare options. The ETF may appeal to investors with a long-term perspective who believe in the continued digitization of healthcare services globally.
Boost Your Returns with SectorSurfer
Award-winning investment strategy automation